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As described elsewhere (Biotechnol Bioeng 2010, 2013), our DXB11 (dhfr–) host cell engineering strategy 
achieved high cell viability for a prolonged period (more than 1 month) and enhanced mAb productivity (>100 
pg/cell/day) by nutritional control. Introduction of taurine transporter (TAUT) into DXB11 parent cells increased 
glutamine uptake and accelerated glutathione metabolism. By forcing the overexpression of TAUT, we were able 
to control DXB11 host cell functions and thereby increase the monoclonal antibody (mAb) titer up to 
8.1 g/L/31 days under conventional 1-L bioreactor fed-batch conditions. Furthermore, the mAb produced by the 
DXB11/TAUT cells was comparable in quality to the mAb produced by the parent cells.  
 
In this study, we used CHO-K1 host cells and a chemically defined medium (CDM) for the development of cell 
lines producing recycling antibodies (rcAb). CDM adaptation and TAUT overexpression improved CHO-K1 cell 
performance. Rapid-growth CHO-K1/TAUT cells were developed, and these enabled the establishment of strains 
that produced higher yields of rcAb than did CHO-K1 parent cell (p < 0.05). Viable cell density of these CHO-
K1/TAUT/rcAb strains increased not only under shaker passage culture conditions (p < 0.01) but also under 
shaker fed-batch culture conditions (p < 0.01).  
 
These results suggest that our TAUT overexpression strategy also has a unique potential for the improvement of 
CHO-K1 host cells as well as DXB11 host cells. 
